Jump to navigation

Draft pandemic treaty could force Big Pharma to share vaccines with developing countries

Major battles lie ahead as negotiations on a new treaty to set rules for production and distribution of life-saving drugs

Negotiations on protocols for a global and national level pandemic response have started with the World Health Organization's (WHO) Intergovernmental Negotiating Body's (INB) publication of a 'zero-draft' of a new pandemic treaty last week.

The draft states that the WHO is 'deeply concerned by the gross inequities' of supply, production and access to Covid-19 vaccines. Its proposal to reserve at least 20% of any tests, vaccines or treatments for use in poorer countries is likely to prompt major pushback from pharmaceutical giants.

Civil society groups say the treaty should compel governments to commit to sharing medical technology and knowhow. It also states that the intellectual property rules that uphold pharmaceutical company monopolies must be waived automatically when a health emergency is declared.

This points to the need for clear enforcement of the treaty which raises another raft of diplomatic questions. The WHO insists the treaty should be legally binding.

The draft cites the backdrop to its recommendations as the 'catastrophic failure of the international community in showing solidarity and equity in response to the novel Covid-19 pandemic'. The final draft is set to be presented at the World Health Assembly in 2024.

Other proposals in the draft include strengthening and sustaining capacities of health systems, cooperation for sustainable and predictable financing, and raising pandemic and public health literacy for pandemic prevention, preparedness, response and recovery.

It also calls for the establishment of the WHO Global Pandemic Supply Chain and Logistics Network to promote production and transfer of technology and know-how.

This network would boost research and development capacities and establish a Pathogen Access Benefit-Sharing System (PABS) to ensure equitable and timely sharing of pathogens with pandemic potential and genomic sequences.



Related Articles

A state of disconnect

African treasuries are putting a positive spin on their own finances, but the message from the markets is grim. Something has to give

The message from African finance ministers is that while the overall picture facing the continent is bleak in the wake of the coronavirus pandemic, many economies are resilient...

READ FOR FREE

Third wave threatens the continent

Lack of international consensus on the response to the virus multiplies risks to Africa's economies and healthcare

Top African and UN officials are desperately lobbying a divided international system for a US$100 billion emergency fund to combat what they fear will be a third wave...


Sparring for a jab

Trade and production deals may help the region’s vaccination drive in the short term more than lobbying for changes to the IP and patent laws

The challenge to access vaccines against Covid-19 is not just an African problem, it is a global battle. But it has shone a spotlight on the complexities that...

READ FOR FREE

Fatigue may be fatal

Africa's health ministers watch with alarm the disastrous fatality rate as the second wave of the virus rips across India

The Covid-19 experience in Africa has been something of a rollercoaster ride. Early predictions were calamitous, then it seemed to pass ominously mildly (unless you were in South...